364 related articles for article (PubMed ID: 18586919)
41. NCCN: Chronic myelogenous leukemia.
Wetzler M;
Cancer Control; 2001; 8(6 Suppl 2):44-8. PubMed ID: 11760557
[No Abstract] [Full Text] [Related]
42. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
[No Abstract] [Full Text] [Related]
43. Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression.
Brazma D; Grace C; Howard J; Melo JV; Holyoke T; Apperley JF; Nacheva EP
Genes Chromosomes Cancer; 2007 Nov; 46(11):1039-50. PubMed ID: 17696194
[TBL] [Abstract][Full Text] [Related]
44. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
Takagi K; Nakamura T; Misaki H; Ueda T
Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
[TBL] [Abstract][Full Text] [Related]
45. Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics.
Gozzetti A; Bocchia M; Crupi R; Calabrese S; Pirrotta MT; Raspadori D; Defina M; Algeri R; Lauria F
Cancer Genet Cytogenet; 2008 Jan; 180(1):83-4. PubMed ID: 18068541
[No Abstract] [Full Text] [Related]
46. Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia.
Otero L; Ornellas MH; Dobbin J; de Souza Fernandez T
Int J Lab Hematol; 2008 Aug; 30(4):346-8. PubMed ID: 18665834
[No Abstract] [Full Text] [Related]
47. Out of frame peptides from BCR/ABL alternative splicing are immunogenic in HLA A2.1 transgenic mice.
Casnici C; Volpe G; Lattuada D; Crotta K; Kuka M; Panuzzo C; Mastrotto C; Tonon G; Fazio VM; Saglio G; Marelli O
Cancer Lett; 2009 Apr; 276(1):61-7. PubMed ID: 19062160
[TBL] [Abstract][Full Text] [Related]
48. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
[TBL] [Abstract][Full Text] [Related]
49. [Acute myelogenous leukemia and myelodysplastic syndrome after treatment with cytostatic agents].
Abrahamsen AF
Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2542-5. PubMed ID: 11070993
[TBL] [Abstract][Full Text] [Related]
50. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
51. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
[TBL] [Abstract][Full Text] [Related]
52. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
[TBL] [Abstract][Full Text] [Related]
53. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
[TBL] [Abstract][Full Text] [Related]
54. Development of myelodysplastic syndrome in a patient with chronic myelogenous leukemia treated with imatinib.
Mallik N; Chopra A; Jha A; Gogia A; Kumar R
Leuk Lymphoma; 2015 Apr; 56(4):1143-4. PubMed ID: 25093381
[No Abstract] [Full Text] [Related]
55. Prolonged preleukemic phase of chronic myelogenous leukemia.
Hudnall SD; Northup J; Panova N; Suleman K; Velagaleti G
Exp Mol Pathol; 2007 Dec; 83(3):484-9. PubMed ID: 17931622
[TBL] [Abstract][Full Text] [Related]
56. The short arm of chromosome 18 is a recurrent integration site of a supernumerary BCR/ABL gene fusion in chronic myeloid leukemia.
Metzke-Heidemann S; Harder L; Gesk S; Grimm W; Siebert R
Cancer Genet Cytogenet; 2007 Dec; 179(2):156-8. PubMed ID: 18036405
[No Abstract] [Full Text] [Related]
57. Chronic myeloid leukaemia and occupational exposure to benzene in a Royal Navy submariner.
Dean MR
J R Nav Med Serv; 1996; 82(1):28-33. PubMed ID: 8776936
[TBL] [Abstract][Full Text] [Related]
58. A novel five-way chromosomal translocation observed in chronic myelogenous leukemia.
Ikuta K; Torimoto Y; Jimbo J; Inamura J; Hosoki T; Shindo M; Sato K; Takahashi H; Kohgo Y
Cancer Genet Cytogenet; 2008 May; 183(1):69-71. PubMed ID: 18474301
[TBL] [Abstract][Full Text] [Related]
59. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
[TBL] [Abstract][Full Text] [Related]
60. A cryptic chromosome 19 abnormality in a patient with Ph-positive acute lymphoblastic leukemia.
Berger R; Busson M; Romana SP
Cancer Genet Cytogenet; 2006 Feb; 165(1):79-80. PubMed ID: 16490601
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
